Skip to main content

Table 5 Adverse events possibly or probably related to the study drug

From: Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial

 CTRX (n = 124)ABPC/SBT (n = 139)p-value
Diarrhea1270.23
Rash570.55
Elevated AST or ALT441.00
Leukopenia111.00
Nausea111.00
Fever100.48
Elevated creatine kinase100.48
Total25 (22 patients)20 (19 patients) 
  1. CTRX Ceftriaxone, ABPC/SBT Ampicillin/sulbactam, AST Aspartate aminotransferase, ALT Alanine aminotransferase